W
Wefight
A leading digital health company that creates and develops a Virtual Companion to support every patients with cancer and chronic diseases
About Wefight
Wefight was a digital health company founded in Montpellier, France, in 2017 by Benoît Brouard and Pierre Nectoux. The firm ceased operations, entering into liquidation in December 2023. The founding of Wefight was inspired by Brouard's experiences as a hospital pharmacist, where he identified a need for accessible and reliable information for patients with chronic conditions. Brouard, who served as CEO, combined his healthcare background with Nectoux's technical expertise as CTO to create the company's core product. Over its operational years, Wefight secured $13.8 million in funding over two rounds, with a significant Series A round of $11.8 million in September 2021 led by Digital Health Ventures and Impact Partners.
The company developed Vik, an AI-powered virtual companion designed to support patients with cancer and chronic diseases. Available as a mobile and web-based chatbot, Vik provided patients and their relatives with 24/7 answers to their questions, offering scientifically backed information to alleviate anxiety and isolation. The content for each condition-specific Vik application was co-created with patient advocacy groups, patients, and scientific committees to ensure relevance and accuracy. Vik's functionalities included educating patients about their diagnosis and treatment, helping them manage their condition, and providing reminders for medication adherence. The platform supported over 15 pathologies and was available in several countries, including the US, Canada, Brazil, and nations across Europe and the Middle East.
Wefight's business model targeted several stakeholders within the healthcare ecosystem. For patients, the Vik app was free to use. Revenue was generated through partnerships with pharmaceutical companies, which utilized the platform for patient engagement and to gather real-world data. The company offered several solutions, including 'Vik Studies' to conduct tailored research, 'Vik PROM' to capture patient-reported outcome measures, and 'MedVik', a platform for healthcare professionals to monitor their patients remotely. This model allowed Wefight to provide pharmaceutical clients with anonymized real-world evidence to enhance patient care and support clinical trials.
Source: Dealroom company dataAt a glance
- Status
- Closed
- Employees
- 2
- Open positions
- None listed
- Industry
- Health
- Sub-industry
- Health Platform
- Sector
- Oncology, Mental Health, Patient Care, Headstart (EIT Health), European Health Catapult (EIT Health), Product Market Fit (EIT Health), Investor Network (EIT Health), Bridgehead Europe (EIT Health)
- Technology
- Artificial Intelligence, Mobile app
- Business model
- SaaS
- Client focus
- B2C
News
Open roles
Funding history
Company financing events and reported valuations.
Growth signals
Latest recorded traffic for Wefight is 12K monthly website visits, down 14.3% over the last three months. Wefight's team declined 92.3% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Wefight in the Paris ecosystem
The Wefight office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A6 investors entered at this stage
Angels Santé- MAMelies Business Angels
Investir & +
Impact Partners
Digital Health Ventures
Business Angels Des Grandes Ecoles
Other known investors3 additional known investors
EIT Health
HEC Paris
HEC Challenge+
Source: Dealroom Talent Intelligence.
See Wefight’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.










